Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Share News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Innovations CEO steps down

Wed, 17th Jul 2013 10:39

Technology commercialisation and investment group Imperial Innovations confirmed that Chief Executive Susan Searle has stepped down after 11 years in the role. Chief investment officer Russ Cummings, who has been a director since the group's flotation in 2006, has taken over as CEO with immediate effect. Cummings has previously worked at Scottish Equity Partners where he was responsible for investment in high growth technology companies. Chairman Martin Knight commented: "During her tenure, Susan Searle transformed the group from an operational division of Imperial College London, as its technology transfer office, to a major independent venture capital and technology licensing business.""Thanks to her efforts, Innovations now has a stable platform from which it can deliver its long-term ventures and licensing business objectives."CJ
More News
25 Mar 2015 06:14

Earnings, Trading Statements Calendar - Week Ahead

Read more
24 Mar 2015 15:58

Earnings, Trading Statements Calendar - Week Ahead

Read more
24 Mar 2015 06:23

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Mar 2015 16:08

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Mar 2015 06:31

Earnings, Trading Statements Calendar - Week Ahead

Read more
20 Mar 2015 16:26

Earnings, Trading Statements Calendar - Week Ahead

Read more
18 Mar 2015 08:51

Imperial Innovations portfolio company gets US drug approval

Technology transfer and investment group Imperial Innovations said its portfolio company Cell Medica received an orphan drug designation by the US Food and Drug Administration. The designation for Cell's cancer immunotherapy product CMD-003 means the group now qualifies for seven years of market exc

Read more
18 Mar 2015 07:59

Imperial Innovations Portfolio Company's Drug Gets Orphan Designation

Read more
19 Feb 2015 09:08

Imperial Innovations' Cell Medica Begins Manufacturing In Berlin

Read more
14 Jan 2015 12:31

Imperial Innovations Commits To Veryan Funding Round

Read more
16 Oct 2014 21:20

Thursday tips round-up: Weir Group, Imperial Innovations

Having failed in its bid to purchase Finnish group Metso Weir Group purchased Trio, a far smaller outfit, marking its first bolt-on acquisition since the start of last year. Trio specialises in comminution, the process by which large rocks are crushed so as to allow miners to get more easily to the

Read more
15 Oct 2014 10:05

Imperial Innovations Profit Up As Portfolio Boosted By Circassia IPO

Read more
8 Oct 2014 07:15

Imperial Innovations Invests GBP1.9 Million In Kesios Therapeutics

Read more
8 Jul 2014 13:21

Woodford reveals top 10 holdings dominated by pharma and tobacco

Highly influential fund manager Neil Woodford has revealed the top 10 stocks in his new £1.6bn Woodford Equity Income fund, including new favourites Imperial Innovations and Rolls-Royce. The university technology spin-out group and the aircraft engine-maker did not feature in the manager's previous

Read more
7 Jul 2014 10:23

TOP NEWS: Three More Healthcare And Tech Firms Set For London IPO

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.